Amgen Management Performance

Amgen Inc -- USA Stock  

USD 186.64  0.88  0.47%

Analysis of Amgen manpower and management performance can provide insight into Amgen stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Amgen Inc future performance. Check also Trending Equities.

Amgen Management Effectiveness

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.

Amgen Profit Margins

The company has Profit Margin (PM) of 35.46 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 44.49 % which suggests for every 100 dollars of sales it generated a net operating income of 0.44.

Amgen Insider Trading

Amgen Stakeholders

Robert Bradway Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee
Brian McNamee Executive Vice President - Full Potential Initiatives
Esteban Santos Executive Vice President Operations
Jonathan Graham Senior Vice President General Counsel, Secretary
Sean Harper Executive Vice President - Research and Development, Ph.D
Stuart Tross Senior Vice President - Human Resources
Lori Johnston Senior Vice President - Human Resources
Cynthia Patton Senior Vice President Chief Compliance Officer
David Piacquad Senior Vice President - Business Development
David Meline CFO and Executive VP
Madhavan Balachandran Executive VP of Operations
Anthony Hooper Executive VP of Global Commercial Operations
Frank Herringer Independent Director
R Williams Director
Francois Carbonnel Independent Director
Rebecca Henderson Independent Director, Ph.D
Sanders Williams Independent Director
Vance Coffman Lead Independent Director, Ph.D
Tyler Jacks Independent Director, Ph.D
Gregory Garland Independent Director
Charles Holley Director
Ellen Kullman Director
Frank Biondi Independent Director
Ronald Sugar Independent Director
Robert Eckert Independent Director
Greg Garland Independent Director
Judith Pelham Independent Director
David Baltimore Independent Director, Ph.D
Fred Hassan Director
Annette Such Chief Accounting Officer
Arvind Sood IR Contact Officer

Leadership

Amgen Top Executives
Robert Bradway  Chairman
Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee
Brian McNamee  President
Executive Vice President - Full Potential Initiatives

Tenure Analysis

Amgen Employment Tenure
Amgen employes about 17900 people. The company is managed by 31 executives with total tenure of roughly 169 years, averanging almost 5.0 years of service per executive having 577.0 employee per reported executive.

Earnings

Amgen Earnings Estimates
EPSEstimate Date
Quarterly Estimate2.99April 27, 2017
Amgen Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Manpower Efficiency

Return on Amgen Manpower
Revenue Per Employee 1.3 M
Revenue Per Executive 743.5 M
Net Income Per Employee 415.1 K
Net Income Per Executive 263.5 M
Working Capital Per Employee 1.7 M
Working Capital Per Executive 962.9 M

Per Employee

Amgen Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

Number of Employees

Amgen Number of Employees Analysis
Amgen Inc is rated fifth in number of employees category among related companies. The total workforce of Pharmaceuticals And Biosciences industry is presently estimated at about 175,326. Amgen retains roughly 17,900 in number of employees claiming about 10% of equities listed under Pharmaceuticals And Biosciences industry.

Earnings Per Share

Amgen Inc Earnings Per Share
According to company disclosure Amgen Inc has Earnings Per Share of 10.98 times. This is 1364.0% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceuticals And Biosciences industry, The Earnings Per Share for all stocks is 377.39% lower than the firm.
Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.